Victor Kenyon

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Cell Cycle Arrest

Artificial Intelligence

Endoplasmic Reticulum

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Cigdem Alkan, Terrence O'Brien, Victor Kenyon, Tetsuro Ikegami
Computer-Selected Antiviral Compounds: Assessing In Vitro Efficacies against Rift Valley Fever Virus. Viruses 16 (1) (2024)
Cigdem Alkan, Terrence O'Brien, Victor Kenyon, Tetsuro Ikegami
Computer-Selected Antiviral Compounds: Assessing In Vitro Efficacies against Rift Valley Fever Virus. Viruses 16 (1) (2024)
Cigdem Alkan, Terrence O'Brien, Victor Kenyon, Tetsuro Ikegami
Computer-Selected Antiviral Compounds: Assessing In Vitro Efficacies against Rift Valley Fever Virus. Viruses 16 (1) (2024)
Simon Wheeler, Meenakshi Bhardwaj, Victor Kenyon, Maria J Ferraz, Johannes M F G Aerts, Daniel Sillence
Mitochondrial dysfunction in NPC1-deficiency is not rescued by drugs targeting the glucosylceramidase GBA2 and the cholesterol-binding proteins TSPO and StARD1. FEBS letters 598 (4) (2024)
Simon Wheeler, Meenakshi Bhardwaj, Victor Kenyon, Maria J Ferraz, Johannes M F G Aerts, Daniel Sillence
Mitochondrial dysfunction in NPC1-deficiency is not rescued by drugs targeting the glucosylceramidase GBA2 and the cholesterol-binding proteins TSPO and StARD1. FEBS letters 598 (4) (2024)
Simon Wheeler, Meenakshi Bhardwaj, Victor Kenyon, Maria J Ferraz, Johannes M F G Aerts, Daniel Sillence
Mitochondrial dysfunction in NPC1-deficiency is not rescued by drugs targeting the glucosylceramidase GBA2 and the cholesterol-binding proteins TSPO and StARD1. FEBS letters (2024)
Cigdem Alkan, Terrence O'Brien, Victor Kenyon, Tetsuro Ikegami
Computer-Selected Antiviral Compounds: Assessing In Vitro Efficacies against Rift Valley Fever Virus. Viruses 16 (1) (2024)
Cigdem Alkan, Terrence O'Brien, Victor Kenyon, Tetsuro Ikegami
Computer-Selected Antiviral Compounds: Assessing In Vitro Efficacies against Rift Valley Fever Virus. Viruses 16 (1) (2024)
Priyanka Parijat, Seetharamaiah Attili, Zoe Hoare, Michael J Shattock, Victor Kenyon, Thomas Kampourakis
Discovery of a novel cardiac-specific myosin modulator using artificial intelligence-based virtual screening. Nature communications 14 (1) (2023)